Maravai Lifesciences Holdings (MRVI) Interest & Investment Income (2022 - 2026)

Maravai Lifesciences Holdings' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• In Q1 2026, Interest & Investment Income fell 41.92% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $10.1 million (down 56.94% YoY), while the FY2025 annual figure was $11.4 million, down 58.27% from the prior year.
• Interest & Investment Income was $1.9 million for Q1 2026 at Maravai Lifesciences Holdings, down from $2.4 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $7.5 million in Q4 2023 to a low of $1.9 million in Q1 2026.
• Historically, Interest & Investment Income has averaged $5.1 million across 5 years, with a median of $6.0 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Interest & Investment Income surged 219.03% in 2023, then sank 60.5% in 2025.
• A 5-year view of Interest & Investment Income shows it stood at $2.3 million in 2022, then soared by 219.03% to $7.5 million in 2023, then fell by 19.08% to $6.0 million in 2024, then plunged by 60.5% to $2.4 million in 2025, then fell by 21.43% to $1.9 million in 2026.
• The last three Interest & Investment Income figures came in at $1.9 million (Q1 2026), $2.4 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.